Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Callaghan Innovation Growth Grant for Pacific Edge

Callaghan Innovation Growth Grant for Pacific Edge

Cancer diagnostics company, Pacific Edge Limited (NZX: PEB) is pleased to advise that it has received an additional grant of up to $3 million to its existing Growth Grant from Callaghan Innovation to enable further research and development of its leading edge cancer diagnostics technology.

Pacific Edge received an initial grant of $4.5 million in February 2014, with funding spread over three years. The grant has been successfully utilised by Pacific Edge to underwrite the development of its suite of Cxbladder products. During the term of the grant Pacific Edge completed and commercialised three products, Cxbladder Triage, Cxbladder Monitor and Cxbladder Resolve. Review by Callaghan Innovation has resulted in the allocation of up to a further $3 million to be spread over two years.

Pacific Edge’s non-invasive, cost effective and easy-to-use, urine-based cancer detection and management tests provide clinicians with accurate data and enhance early detection and timely management of patients.

Since the initial grant was awarded, Pacific Edge has developed and launched three new products in its suite of Cxbladder bladder cancer diagnostics tests, in addition to its original test. All of the four tests address different clinical needs throughout the bladder cancer detection and management pathways - from investigation of haematuria (blood in the urine) through to the management of patients who have the disease and are being regularly monitored in the clinic for recurrence of urothelial cancer.

CEO of Pacific Edge, David Darling, said: “Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients. The Growth Grant supplements Pacific Edge’s own investment into R&D and will enable us to bring new innovations through into new products and product improvements, for the benefit of both clinicians and patients alike.”

ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Smelter: Tiwai Deal Gives Time For Managed Transition

Today’s deal between Meridian and Rio Tinto for the Tiwai smelter to remain open another four years provides time for a managed transition for Southland. “The deal provides welcome certainty to the Southland community by protecting jobs and incomes as the region plans for the future. The Government is committed to working on a managed transition with the local community,” Grant Robertson said. More>>

ALSO:

Economy: Strong Job Ad Performance In Quarter Four

SEEK Quarterly Employment Report data shows a positive q/q performance with a 19% national growth in jobs advertised during Q4 2020, which includes October, November and December. Comparing quarter 4, 2020, with the same quarter in 2019 shows that job ad volumes are 7% lower...More>>

NIWA: 2020 - NZ’s 7th-warmest Year On Record

The nationwide average temperature for 2020, calculated using stations in NIWA’s seven-station temperature series which began in 1909, was 13.24°C (0.63°C above the 1981–2010 annual average). New Zealand’s hottest year on record remains 2016, when... More>>

Quotable Value New Zealand: Property Market Set To Cool From Sizzling To Warm In 2021

Nostradamus himself could not have predicted the strange series of events that befell our world in 2020 – nor the wild trajectory of New Zealand’s property market, which has gone from “doom and gloom” to “boom and Zoom” in record time. Even ... More>>

PriceSpy: Research Reveals How Shopping Behaviours Have Changed This Christmas

According to a new survey* from PriceSpy , almost 50 per cent of Kiwis are looking to shop locally this Christmas in light of Covid-19; The research also found consumers are changing their shopping habits, with one in seven (14 per cent) getting super-organised ... More>>

Commerce Commission: Noel Leeming Group Warned For Making Delivery Representations Without Reasonable Grounds During COVID-19 Lockdown

Noel Leeming Group has been warned by the Commerce Commission for making delivery representations about two products which, in the Commission’s view, it did not have reasonable grounds for at the time the representations were made. The warning ... More>>